chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experience extreme brain fog after the first shot but I was unable to pinpoint it to the gardasil shot because covid had just hit the scene and that was one of the many symptoms being thrown out to the public.  I woke up and thought I was having a heart attack after my second shot.  Felt like heart was beating out my chest but eventually subsided and went away within a couple hours. Left side of my chest and my heart has been aching ever since.  Heart murmurs and murmurs from both sides of the chest daily, frequently.   Dizziness when standing up from a siting or laying position so bad I need to take a deep breath before I rise.  If I drink coffee I will pass out for sure.  Tingly and loss of sensation in my fingertips on my left hand when I shower.   I just got health insurance as I had lost my ability to perform my job correctly due to the side effects I'm suffering from and lost my insurance.  I know its from the gardasil shot because before the shot I was perfectly fine.
urinating profusely; headache; nausea; fatigue; A spontaneous report was received from a consumer concerning a 76-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the events headache, nausea, fatigue, and urinating profusely.  The patient's medical history was not provided. Other relevant concomitant medicines include an extensive amount of medications which were not documented and the patient ha a long medical history for her age which was not documented as well.  On 20 Jan 2021, prior to the onset of the events the patient received the first of two planned doses of mRNA-1273 (lot/batch: 0320L2A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 20 Jan 2021, the patient experienced the events of headache, nausea, fatigue,  and urinating profusely after receiving the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, headache, nausea, fatigue, and urinating profusely was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Right arm, deltoid region : 4x6 cm indurated. Pink, non-tender, itchy.
Pt states she felt dizzy. EMT got behind pt and pt fell into staff.  Pt passed out unconscious with eyes wide open, c-spine stabilized. Jaw clenched shut, held her breath, turned blue, sternal rub performed, jaw thrust maneuver performed.  Pt in decerebrate posturing, bladder incontinent during episode.  Emergency services called. Pt became alert, hyperventilating, began crying.  Staff assisted her to cot. States no previous medical history, no allergies, ate two hours prior to vaccination. VSS, pt continuing to hyperventilate and cry.  EMS arrived on site and took over. Placed 20g IV in RAC, drew blood, bgl 122.Pt and all belongings taken to Community Hospital by EMS. Pt was AOX4 GCS 15 at time of tx
Nurse calling to report that a mom wanted her daughters vaccine schedule "split up"/VARIVAX was administered less than 28 days after the MMRII; This spontaneous report was received from a Registered Nurse and refers to a 1-year-old female patient. No information was provided regarding the patient's medical history, concurrent conditions, previous drug reactions and allergies. Concomitant medications included measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II), hepatitis a vaccine (manufacturer unknown) and pneumococcal vaccine (manufacturer unknown).  On 02-JUN-2022, 3 weeks after administration of measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R II) (Also reported as "less than 28 days after the MMRII"), the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis (Inappropriate schedule of product administration). It was stated that the patient's mom wanted her daughters vaccine schedule "split up", so that she would only receive 2 vaccines at a time. The Nurse stated that she thought it had been the full 28 days since the last visit and the varicella virus vaccine live (oka/merck) (VARIVAX) was administered less than 28 days after the measles (+) mumps (+) and rubella (wistar ra 27-3) virus vaccine (+) live (M-M-R ). She was requesting information on weather she will need to repeat the varicella virus vaccine live (oka/merck) (VARIVAX).
On February 9, 2021, I noticed my left upper arm was warm and itchy.  A red blotch, including the injection site,  measured about 4x3 inches.  Today, 2/10/21, I noticed  a slight redness just above my left elbow that is not warm or itchy.
Interchange of vaccine products; patient got positive with Covid. Patient was vaccinated with Moderna and Pfizer Covid 19 Vaccine already; patient got positive with Covid. Patient was vaccinated with Moderna and Pfizer Covid 19 Vaccine already; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna covid-19 vaccine (DOSE NUMBER UNKNOWN, SINGLE), for Covid-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "patient got positive with Covid. Patient was vaccinated with Moderna and Pfizer Covid 19 Vaccine already". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Caller, an HCP would like to know how long can the patient be vaccinated with Pfizer Covid 19 booster if the patient got positive with Covid. Patient was vaccinated with Moderna and Pfizer Covid 19 Vaccine already.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a lack of efficacy under interchange of vaccine products with the suspect vaccine bnt162b2 omi xbb.1.5 in this patient cannot be completely excluded.
Patient presented to pharmacy requesting COVID vaccine booster shot.  A vaccination card was presented indicating Pfizer administered on 2/26/21 and 3/26/21. Confirmed that patient did want to change to Moderna from Pfizer for a booster dose.  After administration and observation, the patient's dose was reported to the local Immunization Service.  It was discovered that the patient received a third dose of Pfizer on 8/27/21 from his family physician.  Due to the New Year's holiday weekend, we were not able to confirm vaccination with the office or patient until 1/3/22.  Both confirmed a third dose was administered on 8/27/21,  It was explained to the patient that this dose was out of series and not indicated.  He was asked to report any adverse effects which may occur.
I looked at the clinic list in the morning. This patient`s DOB is and i miscalculated and thought that he had just turned 16. Patient came in at 5:40pm for his booster and the mother said he was here for his booster. I verified that it was at least 6 months from his 2nd dose, and since the kid was tall and 132 lbs... It never triggered in my mind to double check his age again. I noticed the error around 7:30pm when we finished batching. I called the doctor`s office and notified the nurse right away. The nurse took down the info and said that she will double check with the doctor and notify him as well. I then called and spoke to the patient`s parents and notified them also of the error. The parents were already aware as the nurse had called them already. I told them that it`s the same vaccine and dose as the first 2 shots and that most likely there shouldn`t be any issue. I told them that it`s an issue only because the has set the booster age from 16 and up. The parents said they scheduled the appt online and the system never blocked them from scheduling. They were concerned something might happen to their son. I told them to monitor should something happen and also to keep us updated on how he is doing.
devel difficulty breathing, heart fluttering squad called transported to ER; EPi administered prior to transport; given DPH by ER; sx devel 1 1/2 hrs p/vax still present next day inc HR; also dx w/pneumonia next day;
I had my annual physical on Nov 3 with my Dr..  As part of physical had blood test and cat scan scheduled.  Blood test done on Nov. 8 and cat scan done on Nov 10.
Pt was given Pfizer vaccine dose #1 and patient's face became flushed within 1 minute of administration. Pt has hx of multiple allergies. Pt was asked to take mask off and redness subsided within 5 mins. Pt then reported having numbness/tingling in tongue and lips. Pt was monitored for a total of 36 minutes per RN. Pt reported no further symptoms and noted improvement of symptoms. She was discharged to home with husband, who was also present for the event.
pt irritable for 2-3 days; 2FEB spiked fever 105; APAP given; sz (grand mal); in hosp t103.5 APAP supp given; dx ear infect & throat & rash generalized, blotchy & macular papular for 4-7 days; glands swollen; c/o pain when touching neck;
Patient stated couldn't think straight. Felt weak and was hearing voices. She said it was keeping her up all night and she was blacking out.
Gave 1 vial of Menveo, unintentional error dispensing vx; Gave 1 vial of Menveo; This case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The nurse stated that medical assistant gave 1 vial of the Menveo. Menveo vaccine was administered after being inappropriately reconstituted, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The nurse didn't know lot number and date.
Huge welt approx 5 in wide and 5 in long warm on site and itchy, it has gotten bigger since Sat 10/14/06.
fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79 year-old patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Mar2021 16:00 (Lot number: EN6205) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), administration date: 17Feb2021, when the patient was 79 years old, for COVID-19 IMMUNISATION. The following information was reported: FATIGUE (non-serious) with onset 12Mar2021, outcome "recovered", described as "fatigue". Therapeutic measures were not taken as a result of fatigue.  No follow-up attempts are possible. No further information is expected.
Information has been received from a healthcare worker concerning a 53 year old female patient with hypertension and no known allergies, who on 05-APR-2011 was vaccinated with a dose of PNEUMOVAX 23 0.5 ml, intramuscularly in the left upper arm (Lot number 667914/1067Z, expiration date: 28-FEB-2012). The health care worker reported that on 06-APR-2011 the patient went to the office because area around injection site was red, warm to touch and there was a hard bump the size of a quarter at the injection site. The physician recommended cold compress. Laboratory diagnostics studies were not performed. At the time of the report, the patient recovered 4 days later, on 10-APR-2011. This is one of five reports received from the same source. Additional information has been requested.
Vaccine administered, patient fainted sitting in chair.  Nurse able to support patient and use ice pack to help with recovery.
Large rash appeared, hot to the touch, some pain and itching and touch sensitive. Appeared seemingly overnight.
Vaccine was in the morning and late afternoon he threw up twice bright yellow and screamed in pain for two days.
Nov 4 05 awoke w/ extremely bloodshot and watery eyes, Nov 14 & 29 saw Dr because of right eye-double peripheral vision, Dec 6 Awoke with double vision, Dec 7 MRI of head-normal, more visits to doctor & optometrist.  Diagnosis-lateral rectus palsy of right eye
11 January 2021 ~6pm: Patient developed a rash underneath her right arm, neck, trunk that was itchy/burning/painful.  January 12, 2021: Rash spread more under right arm, top arm, belly and back.   January 21, 2021: Patient had been taking benadryl since January 12th, but rash was still present and spreading. Patient came in to see Prev Med Doctor on 21 January.
Shingles vaccine received on 08/11/09. Lesion appeared on 08/18/09.  Diagnosed as shingles on 08/24/09.
Extreme tiredness; sore throat; fever of 99.9; aches; chills; nausea; headache; raspy voice; mucus in head and neck
Flu shot 12-13-11. Nasal congestion, upper respiratory infection cough, sore throat, laryngitis, fatigue, rash small spots covering whole body, mild, sporadic eruptions.
3 1/2 - 4 1/2 days of persistent fever, as high as 104.
On 12/02/2021, the day after my shot, the left side of my face began spasming off and on for approximately 24 hours. After 24 hours it mostly stopped but would twitch again if I pulled the left side of my lip up. This happened almost every time I brushed my teeth or flossed for approximately one month.  On 01/29/2022, I developed severe headaches, as if I was being repeatedly stabbed in the head. I could not function. I almost went to the ER (I have never in my life gone to ER, and have a very high thresh hold for pain), but waited until the morning to go to urgent care. The pain was frequent and severe for a few days. After that it would come and go, pain that stopped me in my tracks, made me bend over and wince, for a few months. I was referred to a neurologist. I was able to see a neurologist in April. By the time I saw the neurologist the headaches were still present but infrequent. The neurologist said it may or may not be from the vaccine, and he has seen other patients with similar scenarios. He ordered an MRI without contrast which came back clear.  Disruption in menstruation. I stopped having my period after my booster in December 2021. I had my first post booster menstrual cycle in August 2022, and a second one in October. Both cycles were not normal for me (the first one was old blood only, and the second one was very light).
SLIGHT TEMPERAL HEADACHE LASTING FOR ABOUT 7 HOURS, JUST A LINGERING  TEMPERAL HEADCHE.  ARM SORENESS FROM SHOT.  NEXT DAY NO SYMPTOMS AT ALL, JUST SORENESS OF ARM.
Patient spiked a 101.5 degree fever on 9/22/09.  She developed red bumps on her trunk noted after her bath today 9/22/09.  She has small vesicles on the trunk.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 67-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included chickenpox (patient had chickenpox twice once as a child and when she was 36 years old). On 8th February 2019, the patient received the 1st dose of SHINGRIX. In February 2019, less than a week after receiving SHINGRIX, the patient experienced headache, general body pain, weakness, tiredness, nausea, injection site swelling, injection site erythema, injection site warmth and skin warm. On an unknown date, the outcome of the headache, general body pain, weakness, tiredness, nausea, injection site swelling, injection site erythema, injection site warmth and skin warm were recovering/resolving. It was unknown if the reporter considered the headache, general body pain, weakness, tiredness, nausea, injection site swelling, injection site erythema, injection site warmth and skin warm to be related to SHINGRIX. Additional details were reported as follows: The patient had the SHINGRIX last Friday and had these symptoms since terrible headache and body aches and very weak and tired and nausea. The patient injection site was still swollen and pink and warm to the touch, most of her upper left arm all the way around. The patient stated that each day had improved symptom wise and hopefully tomorrow it would be gone. The patient was just concerned about getting the 2nd shot. The patient was interested in GSK opinion.
11-years old sister received both Moderna Vaccines; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (11-years old sister received both Moderna Vaccines) in an 11-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (11-years old sister received both Moderna Vaccines). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (11-years old sister received both Moderna Vaccines) had resolved.            No concomitant medications were reported No treatment medications were reported.  The 11 year old sister received both Moderna Vaccines in November 2021.
On July 29, 2021, a Friday, I started coughing a lot and I ignored it. The next day Saturday, July 30, 2021, I coughed all day, just dry hacking. First of August my symptoms where so bad I went to an Urgent care on a Sunday afternoon around 4:15pm. They tested me for Covid and the test came back negative however, the doctor said I had a really bad upper respiratory infection. He prescribes Chlo hist cough syrup and an antibiotic, I don't recall the name. About ten days later I still had the bad cough. On or about August 12, 2021, I went to my PCP doctor, Dr. and him I still wasn't feeling well. Every time I went to the doctors, I would get tested for Covid, test came back negative. Dr. gave me a shot of Depo-Medrol and Z pack. September 7th, I spoke with a family friend who is a doctor, Dr. and I explained my symptoms, and he concluded that I have whooping cough and he wrote me a prescription for another Z-pak. On September 15, 2021, I tested positive for Covid. That same day I went to the hospital and they gave me 4 infections Monoclonal Antibodies.
pain at the injection site; female patient was given a second vaccination of Fluzone Quad of 0.5 ml, in the right deltoid on 10/212019 and first being on 1/24/2020; Initial information was received on 24-Jan-2020 regarding an unsolicited valid non-serious case from a physician.  This case involves a 32 years old female patient who experienced pain at the injection site (injection site pain), while she received INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  The patient's medical history, past medical treatment, vaccination and family history were not provided.  On 21-Oct-2019, the patient received a dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED via an unknown route at an unknown administration site, for prophylactic vaccination. On 24-Jan-2020 ,she received another dose of the same vaccine (lot: UJ254AC, expiry date: 30-Jun-2020) via an unknown route in the right deltoid, for prophylactic vaccination.  On an unknown date, the patient developed injection site pain following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED for prophylactic vaccination.  It was also a case of actual medication error due to extra dose administered.  No laboratory tests were reported.  Final diagnosis was injection site pain.   It was not reported if the patient received any corrective treatment.  The patient outcome was reported as unknown injection site pain.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number is requested (first dose).
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ALLERGIC REACTION, SUBSEQ
had an adverse event; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had an adverse event) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had an adverse event). At the time of the report, VACCINATION COMPLICATION (had an adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
expired dose of Ipol was administered with no reported adverse event; Initial information regarding an unsolicited valid non-serious case was received from an other health professional (Reference number- 00541462) and transmitted to Sanofi on 30-Mar-2021.  This case involves a 9-year-old female patient who received expired dose of POLIOMYELITIS VACCINE (INACTIVATED) (ipol)) [lot R1B251N and expiry date:13-Mar-2021] via an unknown route at an unknown administration site for prophylactic vaccination on 30-Mar-2021.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  It was a case of actual medication error due to expired vaccine used (Latency: on the same day).  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.
Headache, Myalgia, Fever, CoughWheeze, GREENISH PHLEGN Narrative:
MENACTRA was administered to 56 y.o. pt. - only licensed for up to 55 years of age. No adverse reactions were reported.
On 12/16/13 mom brought patient into office reporting anxiety and crying bouts lasting several weeks and triggered by going to school after each of three HPV doses 1/29/13, 4/2/13 and 7/31/13 seen 2/19/13 with onset crying 2/14/13 and school refusal. Behavioral health specialist diagnosed depressive disorder and anxiety and treated with REMERON 4/30/13
1845: hand numbness HR: 102, shaky, reports last meal was 3 hour previous 1904: HR:72, feeling better and requests to go home, decline further care